Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti–tumor necrosis factor α agents
J. Braun, X. Baraliakos, J. Listing, J. Davis, D. van der Heijde, H. Haibel, M. Rudwaleit, J. SieperVolume:
57
Year:
2007
Language:
english
Pages:
9
DOI:
10.1002/art.22669
File:
PDF, 89 KB
english, 2007